Evidence map›Paper›PMID 36701450›Full record

ArticleScience (New York, N.Y.)2023

Low protease activity in B cell follicles promotes retention of intact antigens after immunization.

Aereas Aung, Ang Cui, Laura Maiorino, Ava P Amini, Justin R Gregory, Maurice Bukenya, Yiming Zhang, Heya Lee, Christopher A Cottrell, Duncan M Morgan and 16 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Extracellular vesicles are key mediators for direct antigen transport to draining lymph nodes.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 1 country.

Aereas AungKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0003-2429-5547
Ang CuiBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-1087-8568
Laura MaiorinoKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0001-8217-1337
Ava P AminiKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-8601-6040
Justin R GregoryKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Maurice BukenyaKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-1423-9464
Yiming ZhangKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-8102-3815
Heya LeeKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Christopher A CottrellDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0002-3364-3083
Duncan M MorganKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-3253-1362
Murillo SilvaKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0003-4668-6290
Heikyung SuhKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Jesse D KirkpatrickKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-1487-9568
Parastoo AmlashiKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-4801-1871
Tanaka RembaKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0001-9531-4341
Leah M FroehleRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID 0000-0001-5641-9116
Shuhao XiaoKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-7522-3626
Wuhbet AbrahamKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Josetta AdamsKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0001-6416-2330
J Christopher LoveKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0003-0921-3144
Phillip HuyettDepartment of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1951-3266
Douglas S KwonRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.ORCID 0000-0001-8521-8735
Nir HacohenBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-2349-2656
William R SchiefConsortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0002-1120-0150
Sangeeta N BhatiaKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-1293-2097
Darrell J IrvineKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-8637-1405
Allen Institute · USBroad Institute · USScripps Research Institute · USRagon Institute of MGH, MIT and Harvard · USHarvard–MIT Division of Health Sciences and Technology · USMassachusetts Eye and Ear Infirmary · USMicrosoft (United States) · US

Funding

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antiviralsUM1AI144462 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2019 to 2025
$201.6M
Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MCELRATH, MARGARET JULIANA · 2012 to 2018
$131.5M
VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
Virology and ImmunologyP01AI048240 · NIAID · UNIVERSITY OF WASHINGTON · PI RUPRECHT, RUTH MARGRIT · 2000 to 2020
$46.7M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Postdoctoral Training Program in AIDS-related ResearchT32AI007386 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY, ENGELMAN, ALAN N. · 1990 to 2023
$5.3M
NCI NIH HHS P30 CA014051NIAID NIH HHS P01 AI048240NIAID NIH HHS T32 AI007386NIAID NIH HHS UM1 AI100663NIAID NIH HHS UM1 AI144462NIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

The structural integrity of vaccine antigens is critical to the generation of protective antibody responses, but the impact of protease activity on vaccination in vivo is poorly understood. We characterized protease activity in lymph nodes and found that antigens were rapidly degraded in the subcapsular sinus, paracortex, and interfollicular regions, whereas low protease activity and antigen degradation rates were detected in the vicinity of follicular dendritic cells (FDCs). Correlated with these findings, immunization regimens designed to target antigen to FDCs led to germinal centers dominantly targeting intact antigen, whereas traditional immunizations led to much weaker responses that equally targeted the intact immunogen and antigen breakdown products. Thus, spatially compartmentalized antigen proteolysis affects humoral immunity and can be exploited.

Indexed as

B-LymphocytesEndopeptidasesImmunizationLymph NodesVaccinationAnimalsAntigensGerminal CenterHumansMiceProteolysisAntigensEndopeptidases

Identifiers

PMID36701450
PMCPMC10041875
OpenAlexW4318141600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.